David P. Holveck

David P. Holveck
Director

Mr. Holveck is the President, CEO and Director of Endo Pharmaceuticals Holdings, Inc. He was previously Corporate Vice President, Corporate Development, for Johnson & Johnson. In addition, Mr. Holveck previously served as President, Johnson & Johnson Development Corporation. He joined Johnson & Johnson as a Company Group Chairman in October 1999, with the completion of the merger of Centocor, Inc., and Johnson & Johnson. Prior to joining Johnson & Johnson, he had been Chief Executive Officer of Centocor, Inc., since 1992 and a member of its board of directors since 1994. Prior to joining Centocor, Inc., he had held positions at General Electric Company, Corning Glass Works, and Abbott Laboratories. Mr. Holveck currently serves on the board of University City Science Center in Philadelphia and the Eastern Technology Council. Mr. Holveck is a former board member of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturing Association (PhRMA). He received a Bachelor of Science degree in Education/Science from West Chester University.